Dr Reddys Laboratories

1,170.95
+5.10
(0.44%)
Market Cap
97,705.34 Cr
EPS
335.22
PE Ratio
18.09
Dividend Yield
0.69 %
Industry
Healthcare
52 Week High
1,421.49
52 Week low
1,120.00
PB Ratio
3.16
Debt to Equity
0.06
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from35 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy40.00 %
40.00 %
Hold22.86 %
22.86 %
Sell37.14 %
37.14 %
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,669.30 4,00,520.99 34.13 49,887.20 12.06 9,648 13.77 37.74
5,978.30 1,58,705.08 76.14 8,184.00 0.89 1,600 64.53 51.57
1,479.70 1,19,502.65 23.70 26,520.70 14.17 4,155 47.38 51.15
3,095.95 1,04,781.02 56.64 10,785.70 11.59 1,656 13.54 45.77
1,170.95 97,705.34 18.09 28,905.40 12.36 5,578 1.69 30.83
2,348.45 96,889.27 47.77 10,615.60 19.57 1,942 -16.38 39.42
899.65 90,525.84 19.78 19,831.50 13.82 3,831 29.92 36.77
1,977.50 90,213.07 31.46 20,141.50 19.94 1,936 38.82 38.83
1,121.25 65,122.38 18.72 29,559.20 17.55 3,169 -10.04 42.81
29,429.65 62,535.95 47.37 6,097.20 10.80 1,201 16.01 61.56
Growth Rate
Revenue Growth
12.36 %
Net Income Growth
23.75 %
Cash Flow Change
-22.83 %
ROE
1.96 %
ROCE
-3.56 %
EBITDA Margin (Avg.)
6.12 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
3,887
3,813
4,061
4,030
3,841
3,302
3,630
3,747
3,575
3,354
3,578
3,849
3,580
3,779
3,937
3,961
4,116
4,290
4,867
4,469
4,516
4,512
4,955
5,015
4,829
5,044
5,993
5,394
5,569
6,079
6,361
6,835
6,443
6,917
7,199
7,434
7,284
7,866
8,330
8,513
Expenses
3,271
2,765
2,888
2,996
3,313
2,855
2,989
2,859
3,021
3,010
2,890
3,041
2,990
2,968
3,058
3,060
3,211
3,117
3,749
4,686
3,500
3,305
3,755
4,403
3,715
4,211
4,427
4,123
5,024
4,292
4,433
4,851
4,781
4,696
4,894
5,214
5,283
5,566
5,962
6,108
EBITDA
616
1,048
1,173
1,034
528
447
640
888
553
344
687
808
590
812
879
901
905
1,174
1,118
-217
1,016
1,207
1,200
613
1,114
833
1,566
1,271
545
1,787
1,928
1,983
1,662
2,221
2,305
2,220
2,001
2,300
2,368
2,405
Operating Profit %
15 %
26 %
28 %
25 %
12 %
12 %
17 %
23 %
15 %
9 %
18 %
20 %
15 %
20 %
19 %
21 %
20 %
19 %
22 %
-7 %
21 %
25 %
23 %
11 %
21 %
14 %
23 %
23 %
8 %
18 %
30 %
28 %
24 %
30 %
29 %
28 %
25 %
27 %
26 %
27 %
Depreciation
0
203
224
235
277
244
262
267
254
259
270
272
276
279
279
290
287
289
313
287
274
292
317
311
309
284
294
294
293
302
309
324
316
353
376
374
368
381
397
471
Interest
23
28
22
16
17
15
13
16
20
22
22
17
18
20
21
24
25
30
30
15
23
23
25
19
30
19
23
22
32
35
31
42
35
37
35
39
59
60
76
82
Profit Before Tax
593
831
960
733
273
199
396
622
337
81
409
547
314
529
599
601
606
869
786
-506
736
901
873
295
815
556
1,273
974
259
1,468
1,614
1,638
1,329
1,850
1,917
1,829
1,605
1,883
1,917
1,874
Tax
74
184
185
147
150
45
87
130
-1
14
103
244
42
53
81
101
151
193
-321
33
-45
306
101
267
258
175
277
265
162
279
499
394
369
445
435
448
295
490
576
470
Net Profit
519
647
775
586
123
154
309
492
338
67
305
303
272
476
518
500
455
677
1,107
-538
781
595
772
28
557
380
996
709
97
1,189
1,114
1,244
960
1,405
1,482
1,381
1,310
1,392
1,342
1,404
EPS in ₹
30.45
37.99
45.42
34.34
7.19
9.06
18.64
29.72
20.38
4.02
18.42
18.25
16.39
28.69
31.22
30.16
27.45
40.81
66.78
-32.48
47.12
35.87
46.54
1.68
33.61
22.95
60.03
42.75
5.84
71.64
67.13
74.91
57.79
84.55
89.09
82.94
78.66
83.61
75.40
16.97

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
18,598
20,384
21,817
22,544
22,466
23,225
26,617
29,747
32,285
38,864
Fixed Assets
5,377
6,563
6,931
6,968
7,191
6,850
8,206
8,122
9,219
10,426
Current Assets
11,877
11,794
9,684
10,498
11,110
12,599
14,550
17,782
20,426
24,805
Capital Work in Progress
529
772
3,325
3,471
2,934
1,535
1,565
1,293
1,030
1,419
Investments
2,102
3,833
2,110
2,298
2,587
2,678
2,212
2,616
4,986
4,931
Other Assets
10,590
9,216
9,452
9,808
9,754
12,162
14,634
17,716
17,050
22,088
Total Liabilities
18,598
20,384
21,817
22,544
22,466
23,225
26,617
29,747
32,285
38,864
Current Liabilities
6,821
6,347
8,420
6,894
5,897
7,214
8,104
9,766
8,572
9,588
Non Current Liabilities
1,923
1,467
1,135
3,079
2,545
412
871
769
427
1,021
Total Equity
9,853
12,570
12,262
12,572
14,024
15,599
17,642
19,212
23,286
28,255
Reserve & Surplus
9,768
12,485
12,179
12,489
13,994
15,616
17,755
19,289
23,330
28,271
Share Capital
85
85
83
83
83
83
83
83
83
83

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-280
-47
-114
-124
-31
-27
1,286
3
-907
133
Investing Activities
-2,370
-1,610
-1,890
-1,483
-769
-495
-2,255
-2,565
-4,109
-4,034
Operating Activities
2,524
3,263
2,144
1,803
2,870
2,984
3,570
2,811
5,888
4,543
Financing Activities
-433
-1,700
-369
-444
-2,133
-2,516
-30
-242
-2,686
-376

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
26.74 %
26.73 %
26.72 %
26.72 %
26.72 %
26.71 %
26.71 %
26.70 %
26.70 %
26.69 %
26.66 %
26.65 %
26.65 %
26.65 %
26.64 %
26.64 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
42.21 %
0.00 %
44.49 %
42.27 %
41.75 %
40.08 %
DIIs
14.25 %
15.08 %
20.92 %
21.95 %
24.46 %
24.95 %
24.47 %
23.38 %
23.05 %
21.99 %
21.04 %
16.21 %
18.31 %
20.73 %
21.48 %
22.90 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
8.31 %
7.76 %
8.14 %
8.27 %
8.37 %
8.22 %
8.06 %
7.84 %
7.59 %
7.51 %
7.91 %
8.44 %
8.25 %
8.07 %
8.07 %
8.07 %
Others
50.70 %
50.43 %
44.22 %
43.07 %
40.45 %
40.12 %
40.76 %
42.08 %
42.66 %
43.80 %
2.18 %
48.69 %
2.30 %
2.29 %
2.06 %
2.30 %
No of Share Holders
2,21,107
2,23,309
2,55,720
2,42,376
2,63,803
2,55,300
2,59,271
2,46,788
2,32,715
2,46,769
2,43,445
2,57,794
2,55,500
2,67,694
3,10,403
4,03,669

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 20 20 20 20 25 25 30 40 40 0.00
Dividend Yield (%) 3.8 4.81 3.6 3.2 2.77 2.91 3.24 3.25 3.43 0.00

Corporate Action

Announcements

Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
6 days ago
Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations 2015
8 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
9 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication
Feb 06, 2025, 21:13
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015
Feb 06, 2025, 15:53
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 05, 2025, 16:20
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 04, 2025, 17:42
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 04, 2025, 17:40
Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations 2015
Feb 03, 2025, 22:18
Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations 2015
Feb 02, 2025, 18:36
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Jan 29, 2025, 20:27
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Jan 29, 2025, 16:37
Intimation On Filing Of Form 6-K With US SEC For The Quarter And Nine Months Ended December 31 2024
Jan 24, 2025, 13:41
Announcement under Regulation 30 (LODR)-Newspaper Publication
Jan 24, 2025, 13:31
Integrated Filing (Financial)
Jan 24, 2025, 13:15
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Jan 24, 2025, 08:59
Outcome of Board Meeting
Jan 23, 2025, 17:24
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015
Jan 22, 2025, 23:03
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Jan 08, 2025, 15:49
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Jan 07, 2025, 18:44
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Jan 03, 2025, 16:43
Announcement under Regulation 30 (LODR)-Credit Rating
Dec 27, 2024, 18:05
Announcement under Regulation 30 (LODR)-Acquisition
Dec 23, 2024, 19:51
Board Meeting Intimation for Board Meeting Intimation For Approval Of Unaudited Financial Results Of The Company For The Quarter And Nine Months Ending On December 31 2024
Dec 23, 2024, 18:59
Closure of Trading Window
Dec 23, 2024, 18:55

Technical Indicators

RSI(14)
Neutral
30.83
ATR(14)
Less Volatile
29.63
STOCH(9,6)
Neutral
28.78
STOCH RSI(14)
Oversold
10.03
MACD(12,26)
Bearish
-2.06
ADX(14)
Strong Trend
29.59
UO(9)
Bearish
49.32
ROC(12)
Downtrend And Accelerating
-4.43
WillR(14)
Neutral
-69.68